Drug the Undruggable: Learn how Elsie Biotechnologies is advancing oligonucleotide therapeutics

Join our webinar with the Co-Founder and Scientific Director of Elsie Biotechnologies to learn more.

Join us on March 21st for our webinar with Elsie Biotechnologies, an industry leader in oligonucleotide therapeutics, who recently partnered with GSK to revolutionize the development of safer, more effective therapeutics, while pushing the boundaries of drug discovery.

During this webinar, we will discuss:

• A detailed look at the computational design tools and unique high-throughput experimental approaches Elsie Biotechnologies leverages to develop drugs.

• How an external partnership with a large pharmaceutical company, such as GSK, can impact a small biotech.

• A look towards the future of oligonucleotide therapies. 

Register now using the link below. We look forward to seeing you there!